alias:: CSOM
ICD-11_Code::
tags:: #Disease

- ## Etiology
  background-color:: blue
  - ### Causative Agents
  - ### Risk Factors
- ## Epidemiology
  background-color:: blue
  - ### Incidence
  - ### Prevalence
    - ### Demographics
  - ### Geographic Distribution
- ## Pathophysiology
  background-color:: blue
  - ### Mechanism of Disease
  - ### Affected Systems/Organs
- ## Clinical Features
  background-color:: blue
  - ### Signs and Symptoms
    - #### Symptoms
    - #### Signs
  - ### Stages or Classification #ent-prof-written #unanswered #card
    deck:: #ENT
    id:: e02ad0f3-b7ca-4c01-b24b-d23f02d1d618
    - [[Tubotympanic Chronic Suppurative Otitis Media]]
    - [[Anticoantral Chronic Suppurative Otitis Media]]
    - Differences between [[Tubotympanic variety CSOM]] and [[Anticoantral variety CSOM]] #ent-prof-card #unanswered #card
      deck:: #ENT
      id:: 6756c6d1-5755-4374-91b1-8f5ec4f8f6ef
  - ### Diagnostic Criteria
- ### Differences between CSOM safe variety from unsafe variety #ent-prof-written #unanswered #card
  deck:: #ENT
  id:: 6757fca8-097d-4e46-a639-851515f4c2f8
- ## Diagnosis
  background-color:: blue
  - ### Clinical Diagnosis
    - #### Classical Presentation
    - #### Probable Diagnosis
  - ### Investigation
    - deck:: #ENT
      id:: 6756bff6-4066-4836-ad06-539a7077b1ca
      |Test|Interpretation|
      |[[Rinne's Test]]|{{c1 }}|
      |[[Weber Test]]|{{c2 }}|
      #ent-prof-card #unanswered #card
      deck:: #ENT
      id:: 6756bff6-4066-4836-ad06-539a7077b1ca
  - ### Laboratory Tests
  - ### Imaging Studies
  - ### Differential Diagnosis
  - ### Confirmation of Diagnosis
- # Management of a safe variety of CSOM in dry Stage #ent-prof-written #unanswered #card
  deck:: #ENT
  id:: 6757fb4f-2585-4c30-90bc-5e207aac3091
- ## Management and Treatment
  background-color:: blue
  - ### Medical Treatment
  - ### Surgical Options
  - ### Lifestyle and Dietary Recommendations
  - ### Follow-up
- ## Prognosis
  background-color:: blue
  - ### Expected Course
    - #### With Treatment
    - #### Without Treatment
      - ##### Possible Complications #ent-prof-card #ent-prof-written #unanswered #card
        id:: c93f1a22-c346-4a1e-9be1-67b2db2bca1c
        deck:: #ENT
      - ##### Long-Term Effects
  - ### Survival Rates
    - #### With Treatment
    - #### Without Treatment
  - ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
  - ### Health Education
  - ### Community Approach
  - ### Screening Programs
  - ### Lifestyle Modifications
- ## Patient Education and Support
  background-color:: blue
  - ### Educational Resources
  - ### Support Groups
  - ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
  - ### Ongoing Clinical Trials
  - ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue
- #SN Short Note #ent-prof-written #unanswered #card
  deck:: #ENT
  id:: 6757fb69-04f9-42d1-b8e8-d8fb771044e9
